Drug intelligence / Profile preview

Neradin

Development stage: Unknown
Lead developer: PharmaSGP
Modality: Small Molecules
Administration: Oral

Overview

Neradin is an over-the-counter (OTC) product line marketed by PharmaSGP for men's health, specifically targeting sexual weakness and erectile dysfunction. It is available in two primary formulations: a homeopathic tablet and a dietary supplement capsule (Neradin aktiv). The homeopathic tablet contains *Turnera diffusa* (Damiana) at a D4 dilution, which is traditionally used for its aphrodisiac properties. The Neradin aktiv capsule is a multi-ingredient supplement that combines Damiana extract with red ginseng (*Panax ginseng*) and a nutrient complex consisting of zinc, selenium, magnesium, and folic acid. Zinc is included to support the maintenance of normal testosterone levels, while selenium is intended to support healthy spermatogenesis.

Brand names: NeradinNeradin aktiv
Other names: Turnera diffusa trit. D4Damiana

Beyond the preview

Go deeper on Neradin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neradin.

Explore the full profile